1. Home
  2. NVCR vs ADUS Comparison

NVCR vs ADUS Comparison

Compare NVCR & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • ADUS
  • Stock Information
  • Founded
  • NVCR 2000
  • ADUS 1979
  • Country
  • NVCR Jersey
  • ADUS United States
  • Employees
  • NVCR N/A
  • ADUS N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • ADUS Medical/Nursing Services
  • Sector
  • NVCR Health Care
  • ADUS Health Care
  • Exchange
  • NVCR Nasdaq
  • ADUS Nasdaq
  • Market Cap
  • NVCR 1.8B
  • ADUS 2.0B
  • IPO Year
  • NVCR 2015
  • ADUS 2009
  • Fundamental
  • Price
  • NVCR $17.49
  • ADUS $126.02
  • Analyst Decision
  • NVCR Buy
  • ADUS Buy
  • Analyst Count
  • NVCR 5
  • ADUS 9
  • Target Price
  • NVCR $26.60
  • ADUS $132.00
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • ADUS 101.3K
  • Earning Date
  • NVCR 10-30-2024
  • ADUS 11-04-2024
  • Dividend Yield
  • NVCR N/A
  • ADUS N/A
  • EPS Growth
  • NVCR N/A
  • ADUS 26.93
  • EPS
  • NVCR N/A
  • ADUS 4.20
  • Revenue
  • NVCR $549,964,000.00
  • ADUS $1,114,740,000.00
  • Revenue This Year
  • NVCR $16.23
  • ADUS $11.37
  • Revenue Next Year
  • NVCR $6.09
  • ADUS $14.93
  • P/E Ratio
  • NVCR N/A
  • ADUS $30.77
  • Revenue Growth
  • NVCR 8.33
  • ADUS 11.57
  • 52 Week Low
  • NVCR $10.87
  • ADUS $78.35
  • 52 Week High
  • NVCR $24.74
  • ADUS $136.12
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • ADUS 49.94
  • Support Level
  • NVCR $15.61
  • ADUS $127.01
  • Resistance Level
  • NVCR $17.31
  • ADUS $130.60
  • Average True Range (ATR)
  • NVCR 1.29
  • ADUS 2.05
  • MACD
  • NVCR 0.05
  • ADUS -0.22
  • Stochastic Oscillator
  • NVCR 11.59
  • ADUS 44.36

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Share on Social Networks: